Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection


Gastric colonization by Helicobacter pylori increases the risk of gastric disorders, including atrophic gastritis which can be diagnosed based on levels of serum biomarkers like Gastrin and Pepsinogen. We therefore examined the efficacy of a serological-based method namely GastroPanel Blood kit, in diagnosing and scoring gastritis associated to Helicobacter pylori infection. Patients with dyspeptic symptoms were prospectively recruited on voluntary basis at the Yaounde Central Hospital and University Teaching Hospital, from March to July 2011. The degree of atrophy was classified according to levels in patient serum of pepsinogens I and II (PGI and PGII) and Gastrin 17 (G17) and compared with histological profiles as reference method. A specific ELISA test was used for the detection of H. pylori IgG antibodies. In total, 86 volunteers from 21 to 83 years old (mean = 46.4 ± 3.3) were enrolled, including 74.4% of women and 25.6% of men. The prevalence of gastritis was statistically similar between Gastro Blood Panel test and histology used as reference method (89.5% versus 83.7%: p > 0.20). Diagnosis based on serum makers showed high sensitivity (93.1%) in comparison with the reference method. However, the serological based method has diagnosed more atrophic gastritis than the reference (17.4% versus 7.0%: p < 0.01), especially at antrum of stomach with H. pylori infection. The prevalence of H. pylori infection was 81.4% with histology versus 84.9% with serology (GBP) (p > 0.05). Furthermore, the prevalence of H. pylori infection did not differ significantly between serological method (84.9%) and reference method (81.4%). These results suggest that diagnosis of atrophic gastritis and H. pylori infection obtained with an optional serological method (GastroPanel) is in a strong agreement with the biopsy findings, and thus can be a useful non endoscopic assessment of stomach mucosal atrophy in patients with dyspepsia.

Share and Cite:

Noah, D. , Assoumou, M. , Bagnaka, S. , Ngaba, G. , Alonge, I. , Paloheimo, L. and Njoya, O. (2012) Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection. Open Journal of Gastroenterology, 2, 113-118. doi: 10.4236/ojgas.2012.23024.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Di Mario, F., Franzè, A. and Cavallaro, L.G. (2008) Non-invasive approach to diagnosis of upper gastroin- testinal diseases. AREA QUALITà S.r.l.
[2] Kokkola, A., Rautelin, H. and Puolakkainen, P. (1998) Positive result in serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. Journal of Clinical Microbiology, 36, 1808-1810.
[3] Borody, T.J., Andrews, P., Jankiewicz, E., et al. (1993) Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. American Journal of Gastroenterology, 88, 1266-1268.
[4] 2011
[5] research applications/March 2011
[6] 2011
[7] Dixon, M.F., Genta, R.M. and Yardley, J.H. (1996) Classification and grading of gastritis. The updated Sydney system. American Journal of Pathology, 20, 1161-1181. doi:10.1097/00000478-199610000-00001
[8] Burtis, C.A. and Ashwood E.R. (1999) Text Book of Clinical Chemistry. 3rd Edition, 310-319.
[9] Sipponen, P., Harkonen, M. and Arto, A. (2001) Determination of atrophic gastritis from serum sample. Finnish medicine Journal, 38, 3833-3839.
[10] Pasechnikov, V.D., Sergey, C.Z., Sergey, M., et al. (2005) Invasive and non invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: A comparative study. Scandinavian journal of Gastroenterology, 40, 297-301. doi:10.1080/00365520410010607
[11] Varis, K., Sipponen, P., Laxén, F., Samloff, M., Huttunen, J.K., Taylor, P.R., Heinonen, O.P., Albanes, D., Sande, N., Virtamo, J., H?rk?nen, M. and the Helsinki Gastritis Study Group (2000) Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scandinavian Journal of Gastroenterology, 35, 950-956. doi:10.1080/003655200750023011
[12] Suovaniemi, O., Harkonen, M., Paloheimo, L. and Sipponen, P. (2003) GastroPanel: Diagnosing atrophic gastritis from serum providing a tool for evidence-based medicine, Business Briefing Global Health Care, 1-4.
[13] Goedhard, J.G., Biemond, I., Gilians, J.P. and Pals, G. (1985) Serum pepsinogen I levels: assessment of gastric acid secretion. Progress Clinical and Biological Research, 173, 139-146.
[14] Massarrat S. (1985) Serum pepsin activity as a parameter of gastric acid secretion. Hepato-Gastroenterology, 32, 185-190.
[15] Westerveld, B.D., Pals, G., Lamers, C.B., Defize, J., Pronk, J.C., Frants, R.R., Ooms, E.C., Kreuning, J., Kostense, P.J. and Eriksson, A.W. (1987) Clinical signifycance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer, 59, 952-958. doi:10.1002/1097-0142(19870301)59:5<952::AID-CNCR2820590517>3.0.CO;2-G
[16] Kekki, M., Samloff, I.M., Varis, K. and Ihamaki, T. (1991) Serum pepsinogen I and gastrin-17 in the screening of severe atrophic corpus gastritis. Finland. Scandi-navian Journal of Gastroenterology Supplement, 186, 109-116. doi:10.3109/00365529109103997
[17] Varis, K., Kekki, M., H?rk?nen, M., Sipponen, P. and Samloff, I.M. (1991). Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scandinavian Journal of Gastroenterology, 186, 117-123. doi:10.3109/00365529109103998
[18] Sipponen, P, Suovaniemi, O, Harkonen, M. and Palohei- mo, L.I. (2002) Diagnosis of atrophic gastritis from a serum sample. Jordan Medical Journal, 36, 117-121.
[19] V??n?nen, H., Vauhkonne, M., Helske, T., K??ri?nen, I., Rasmussen, M., Tunturi, H., Koskenpato, J., Sotka, M., Turunen, M., Sandstr?mme, R., Ristikankare, M., Jussila, A. and Sipponen, P. (2003). Non endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pep-sinogen 1: A multicenter study. European Journal of Gastroenterology and Hepatology, 15, 885-891. doi:10.1097/00042737-200308000-00009
[20] Pasechnikov, V.D., Chukov, S.Z., Kotelevets, S.M., Mostovov, A.N., Mernova, V.P. and Polyakova, M.B. (2004) Possibilityof non-invassive diagnosis of gastric mucosal precancerous changes. World Journal of Gastroenterol- ogy, 10, 3146-3150.
[21] Cavallaro LG, Moussa AM, Liatoupou S, Comparato G, Bertolini S, Merli R, et al. (2004) Accuracy of “serogical gastric biopsy” in a cohort of dyspeptic patients. Emergencies in Gastroenterology, 6th European Bridging Meeting in Gastroenterology, Kaunas, 32.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.